Synairgen (LON:SNG) Shares Pass Below Two Hundred Day Moving Average of $22.91
Synairgen (LON:SNG) Shares Pass Below Two Hundred Day Moving Average of $22.91
Synairgen plc (LON:SNG – Get Rating) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 22.91 ($0.28) and traded as low as GBX 16.10 ($0.20). Synairgen shares last traded at GBX 16.80 ($0.21), with a volume of 218,665 shares changing hands.
在週四的交易中，Synairgen plc(倫敦股票代碼：SNG-GET)跌破了200日移動均線。該股的200日移動均線為22.91英鎊(合0.28美元)，交易價格低至16.10英鎊(合0.20美元)。Synairgen的股票最後交易價格為16.80英鎊(0.21美元)，成交量為218,665股。
Synairgen Stock Up 5.0 %
Synairgen股價上漲5.0%
The company has a quick ratio of 6.35, a current ratio of 6.35 and a debt-to-equity ratio of 0.09. The company has a market capitalization of £33.83 million and a price-to-earnings ratio of -0.69. The stock's fifty day moving average price is GBX 18.65 and its 200-day moving average price is GBX 22.91.
該公司的速動比率為6.35，流動比率為6.35，債務權益比為0.09。該公司市值3383萬GB，本益比為-0.69。該股的50日移動均線價格為18.65英鎊，200日移動均線價格為22.91英鎊。
About Synairgen
關於Synairgen
(Get Rating)
(獲取評級)
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
Synairgen plc發現和開發治療呼吸系統疾病的藥物。該公司開發的產品有：治療新冠肺炎的乙型吸入型幹擾素SG001；治療感冒和流感引起的哮喘的乙型幹擾素吸入劑；治療或預防慢性阻塞性肺病的乙型幹擾素第二階段臨床試驗；以及治療特發性肺纖維化的LXL2抑制劑。
Recommended Stories
推薦故事
- Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
- This is no Time to Buy Lennar but the Time is Coming
- Game-Changing News For Mullen Automotive
- Inflation and the Energy Crisis are Two Freight Trains on a Collision Course – Here's How to Prepare
- Is Enterprise Products Partners Fairly Valued?
- 拖拉機庫存能否突破杯柄收購點？
- 現在不是購買Lennar的時候，但時機即將到來
- 馬倫汽車公司改變遊戲規則的消息
- 通貨膨脹和能源危機是兩列相撞的貨運列車--以下是如何做好準備的
- 企業產品合作夥伴是否得到公平評價？
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
接受Synairgen Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Synairgen和相關公司的最新新聞和分析師評級的每日簡明摘要。
譯文內容由第三人軟體翻譯。